Cargando…
METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway
Methyltransferase-like 3 (METTL3), a major component of the N6-methyladenosine (m6A) methyltransferase complex, has been suggested to function as an oncogene in several cancers. However, its biological mechanism and the involved pathways in gastric cancer (GC) remain unknown. Here, we reported that...
Autores principales: | Yang, Dong-Dong, Chen, Zhan-Hong, Yu, Kai, Lu, Jia-Huan, Wu, Qi-Nian, Wang, Yun, Ju, Huai-Qiang, Xu, Rui-Hua, Liu, Ze-Xian, Zeng, Zhao-Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054453/ https://www.ncbi.nlm.nih.gov/pubmed/32175271 http://dx.doi.org/10.3389/fonc.2020.00115 |
Ejemplares similares
-
Targeting the cholesterol-RORα/γ axis inhibits colorectal cancer progression through degrading c-myc
por: Wang, Ying-Nan, et al.
Publicado: (2022) -
METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma
por: Li, Ting, et al.
Publicado: (2019) -
METTL3-Mediated ADAMTS9 Suppression Facilitates Angiogenesis and Carcinogenesis in Gastric Cancer
por: Wang, Nuofan, et al.
Publicado: (2022) -
Integrative proteomics and m6A microarray analyses of the signatures induced by METTL3 reveals prognostically significant in gastric cancer by affecting cellular metabolism
por: Peng, Guisen, et al.
Publicado: (2022) -
Identification and Validation of METTL3-Related Molecules for Predicting Prognosis and Efficacy of Immunotherapy in Gastric Cancer Based on m6A Methylome and Transcriptome Sequencing Analysis
por: Chen, Shuran, et al.
Publicado: (2022)